A novel stent, called Universal Partially Covered Removable Self-expanding Stent and Anchoring System for the Treatment of Refractory Benign Esophageal Strictures (UAS-RBS) was designed to improve the treatment of benign esophageal refractory strictures with a novel stent. This study aims at evaluating the safety of this new device.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of all Adverse Device Effects
Timeframe: 6 months
Technical stent placement success
Timeframe: Day 0
Full deployment of stent
Timeframe: Day 0
Technical stent removal success
Timeframe: up to 6 months